TITLE

FEV1 and PEF in COPD management: REPLY

AUTHOR(S)
PEARSON, M G.
PUB. DATE
May 1999
SOURCE
Thorax;May1999, p468
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877105

 

Related Articles

  • PEAK EXPIRATORY FLOW AS A SURROGATE FOR HEALTH RELATED QUALITY OF LIFE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PRELIMINARY CROSS SECTIONAL STUDY. OBASEKI, D. O.; AKANBI, M. O.; ONYEDUM, C. C.; OZOH, O. B.; JUMBO, J.; AKOR, A. A.; ERHABOR, G. E. // Ghana Medical Journal;Jun2014, Vol. 48 Issue 2, p85 

    Background: Health Related Quality of Life (HRQL) measures can capture the non-respiratory effects of Chronic Obstructive Pulmonary Disease (COPD). However the relationship with Peak Expiratory Flow (PEF) is not well understood Aim: To determine the relationship of PEF and quality of life...

  • Is it asthma, COPD, or both? Crockett, Anthony // GP: General Practitioner;5/5/2006, p40 

    The article presents case study of a 79-year-old retired cleaner who smoked 20 cigarettes a day for 25 years before stopping eight years ago. She was chesty as a child but had no problems until a few years ago when she developed gradually worsening breathlessness on exertion with a morning cough...

  • HANDHELD SPIROMETRY AS A TOOL FOR GATHERING QUANTITATIVE RESEARCH DATA IN LUNG CANCER. Chernecky, Cynthia; Mayfield, William; Itkin, E. Lewis // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p470 

    Spirometry values (FEV-1, FVC and FEV-1/FVC%) have not been successful in differentiating values from normal subjects, COPD patients and all lung cancer patients combined. No studies have used handheld spirometry, in newly diagnosed and treatment naive patients with nonsmall- cell lung cancer...

  • Nipping it in the bud: An inspiring mission for prevention and management of COPD. Zhong, Nanshan // Journal of Thoracic Disease;Apr2012, Vol. 4 Issue 2, p102 

    The author discusses the challenges involved in early intervention, prevention and management of chronic obstructive pulmonary disorder (COPD). Several reasons for it include a lack of sensitive and specific indicators or markers for early diagnosis of COPD, the annual decline in forced...

  • Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. Yumin Zhou; Guoping Hu; Dali Wang; Shaoyi Wang; Yujun Wang; Zhigang Liu; Jinxin Hu; Zhe Shi; Gongyong Peng; Shengming Liu; Jiachun Liu; Jingping Zheng; Jian Wang; Nanshan Zhong; Pixin Ran // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/4/2010, Vol. 341 Issue 7784, p1203 

    The article focuses on a study which analyzed if community based integrated interventions have an effect on early prevention and management of chronic pulmonary disease (COPD), especially the annual rate of decline in forced expiratory volume in one second (FEV1). Study participants, aged 40-89...

  • Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease. Ilgin, Duygu; Ozalevli, Sevgi; Kilinc, Oguz; Sevinc, Can; Cimrin, Arif H.; Ucan, Eyup S. // Annals of Thoracic Medicine;Jul-Sep2011, Vol. 6 Issue 3, p141 

    AIM: Walking distance is generally accepted as a functional capacity determinant in chronic obstructive pulmonary disease (COPD). However, the use of gait speed in COPD patients has not been directly investigated. Thus, the aim of our study was to assess the use of gait speed as a functional...

  • What Happens with Airway Resistance (RAW) in Asthma and COPD exacerbation. Jalusic-Gluncic, Tajana // Medicinski Arhiv;2011, Vol. 65 Issue 5, p270 

    Background: To show that during the exarcerbration of asthma and COPD, increased airway resistance is accompanied with decreased spirometry values (FVC, FEV1, FEF50, and PEF) also comes increasing of airway resistance (RAW). Patients and methods: This research included 74 patients, in...

  • Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Donaldson, G. C.; Seemungal, T. A. R.; Bhowmik, A.; Wedzicha, J. A. // Thorax;Oct2002, Vol. 57 Issue 10, p847 

    Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an accelerated decline in lung function and periods of acute deterioration in symptoms termed exacerbations. The aim of this study was to investigate whether these are related. Methods: Over 4 years, peak...

  • Spirometric Correlates of Dyspnea Improvement Among Emergency Department Patients With Chronic Obstructive Pulmonary Disease Exacerbation. Camargo Jr, Carlos A.; Chu-Lin Tsai; Clark, Sunday; Kenney, Patrick A.; Radeos, Michael S. // Respiratory Care;Jul2008, Vol. 53 Issue 7, p892 

    OBJECTIVE: To examine whether change in slow vital capacity (SVC) correlates to dyspnea improvement during emergency department (ED) treatment of chronic obstructive pulmonary disease (COPD) exacerbation. METHODS: We performed a prospective cohort study and enrolled consecutive patients during a...

  • Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Vestbo, J.; Pauwels, R.; Anderson, J. A.; Jones, P.; Calverley, P. // Thorax;Apr2005, Vol. 60 Issue 4, p301 

    Background: Combined treatment with inhaled corticosteroids and long acting β2 agonists is approved for the treatment of chronic obstructive pulmonary disease (COPD), but little is known about the onset of effect of the combination. Methods: Data were used from 1465 patients with COPD entered...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics